This medication was approved by the FDA in November 2023 for chronic weight management in adults who are obese or overweight with at least one weight-related condition, such as hypertension, type 2 diabetes, or high cholesterol
Today, GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro are arguably the closest we have come to a magic bullet. The metabolic results are undeniable, but as prescriptions skyrocket, so does a unique aesthetic concern dominating social media: Ozempic face aging
How you use your soap makes a huge difference to the results you'll see
We believe access to safe and effective metabolic care should be 100% covered and part of comprehensive women's healthcare particularly given implications across fertility, postpartum, menopause, and long-term bone and cardiovascular health in women
We'll keep you on track with reminders and updates
Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future